[Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]

Sroczynski G, Schnell-Inderst P, Muehlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Kraemer A, Siebert U
Record ID 32009100073
German
Authors' objectives:

To perform a decision analysis to systematically evaluate the long-term effectiveness and cost effectiveness of HPV-based primary cervical cancer (CC) screening in the German healthcare context.

Authors' recommendations: Research is needed to acquire evidence-based information on adherence patterns, the impact of screening on quality of life and on decision-analytic evaluation of different integrated screening strategies in mixed vaccinated and unvaccinated populations, and systematic evaluation of different practice patterns in diagnostic work-up and treatment after initial screening results.
Details
Project Status: Completed
Year Published: 2010
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Germany
MeSH Terms
  • Cervical Intraepithelial Neoplasia
  • Diagnosis, Differential
  • Papillomavirus Infections
  • Uterine Cervical Neoplasms
Contact
Organisation Name: German Agency for HTA at the German Institute for Medical Documentation and Information
Contact Address: German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information, Waisenhausgasse 36-38a, D-50676 Cologne Germany
Contact Name: dahta@dimdi.de
Contact Email: dahta@dimdi.de
Copyright: German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA@ DIMDI)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.